A double-blind comparative study of the safety and efficacy of caspofungin versus micafungin in the treatment of candidiasis and aspergillosis-Reference-Cited by-同舟云学术

A double-blind comparative study of the safety and efficacy of caspofungin versus micafungin in the treatment of candidiasis and aspergillosis

Published:2012-10-03 Issue:3 Volume:32 Page:387-397
ISSN:0934-9723
Container-title:European Journal of Clinical Microbiology & Infectious Diseases
language:en
Short-container-title:Eur J Clin Microbiol Infect Dis

Author:

Kohno S.,Izumikawa K.,Yoshida M.,Takesue Y.,Oka S.,Kamei K.,Miyazaki Y.,Yoshinari T.,Kartsonis N. A.,Niki Y.

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10096-012-1754-z.pdf

Reference18 articles.

1. Kriengkauykiat J, Ito JI, Dadwal SS (2011) Epidemiology and treatment approaches in management of invasive fungal infections. Clin Epidemiol 3:175–191

2. Kume H, Yamazaki T, Togano T, Abe M, Tanuma H, Kawana S et al (2011) Epidemiology of visceral mycoses in autopsy cases in Japan: comparison of the data from 1989, 1993, 1997, 2001, 2005 and 2007 in annual of pathological autopsy cases in Japan. Med Mycol J 52:117–127

3. Villanueva A, Gotuzzo E, Arathoon EG, Noriega LM, Kartsonis NA, Lupinacci RJ et al (2002) A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis. Am J Med 113:294–299

4. Mora-Duarte J, Betts R, Rotstein C, Colombo AL, Thompson-Moya L, Smietana J et al (2002) Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 347:2020–2029

5. Maertens J, Raad I, Petrikkos G, Boogaerts M, Selleslag D, Petersen FB et al (2004) Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. Clin Infect Dis 39:1563–1571

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimized Antifungal Therapy for Chronic Pulmonary Aspergillosis;Medical Mycology Journal;2024-07-31

2. Preferred Therapy for Specific Fungal Pathogens;2024 Nelson’s Pediatric Antimicrobial Therapy;2024-02-12

3. Chronic pulmonary aspergillosis: comprehensive insights into epidemiology, treatment, and unresolved challenges;Therapeutic Advances in Infectious Disease;2024-01

4. Chronic Pulmonary Aspergillosis: Clinical Presentation and Management;Seminars in Respiratory and Critical Care Medicine;2023-12-28

5. Instillation of Amphotericin B by bronchoscopy combined with systemic voriconazole in advanced non-small cell lung cancer patients with chronic cavitary pulmonary aspergillosis: A case series and literature review;Journal of Medical Mycology;2023-08